How to Select an EU Authorized Representative for MDR & IVDR Compliance

For non-EU medical device and IVD manufacturers, placing a product on the European market requires appointing an EU Authorized Representative (AR). Under the Medical Device Regulation (MDR - Regulation (EU) 2017/745) and In Vitro Diagnostic Regulation (IVDR - Regulation (EU) 2017/746), the AR is far more than a simple mailing address. This entity serves as the primary contact for EU Competent Authorities and is jointly liable with the manufacturer for defective devices. Selecting the right AR is therefore a critical strategic decision that directly impacts a manufacturer's compliance, risk management, and commercial success. A high-quality AR partner provides deep regulatory expertise and robust quality systems, while a poor choice can lead to compliance gaps, market access delays, and significant legal exposure. This guide provides a comprehensive framework for conducting thorough due diligence to select a reliable and effective EU Authorized Representative. ### Key Points * **Shared Legal Liability:** The EU MDR and IVDR make the Authorized Representative jointly and severally liable with the manufacturer for defective devices, making the AR a true risk-sharing partner. * **Beyond a Mailbox:** An effective AR is an active compliance partner, not a passive administrative service. Their responsibilities include verifying key manufacturer documentation, managing vigilance reporting, and interfacing with regulatory authorities on your behalf. * **Expertise is Non-Negotiable:** The AR must possess deep, current expertise in the MDR/IVDR, relevant MDCG guidance, and Common Specifications, especially for devices of a similar technology and risk class to your own. * **Scrutinize the Mandate Agreement:** The legal mandate must clearly define all roles, responsibilities, and services. Manufacturers must understand which services are included in the base fee and which will incur additional costs. * **QMS and Insurance are Critical:** A potential AR should have a robust Quality Management System (QMS), ideally certified to ISO 13485, and be able to provide proof of adequate liability insurance commensurate with the risk of the products they represent. ## Understanding the AR's Core Responsibilities under MDR & IVDR Before evaluating potential partners, it is essential to understand the specific legal obligations imposed on the Authorized Representative by Article 11 of the MDR. A qualified AR must be equipped to perform these tasks diligently. * **Verification of Compliance Documentation:** The AR must verify that the manufacturer has correctly drawn up the EU Declaration of Conformity and the device's technical documentation. They must also confirm that an appropriate conformity assessment procedure has been carried out. * **Documentation Access:** The AR is required to keep a copy of the technical documentation, the Declaration of Conformity, and any relevant certificates (including amendments and supplements) available for inspection by EU Competent Authorities for the required retention period. * **Cooperation with Authorities:** The AR acts as the manufacturer's primary point of contact for Competent Authorities. They must handle requests for information and documentation, provide device samples if requested, and cooperate with any preventive or corrective actions taken to mitigate device risks. * **Vigilance and Post-Market Surveillance (PMS):** The AR plays a crucial role in the manufacturer's vigilance system. They must be immediately informed by the manufacturer of any complaints or reports from healthcare professionals, patients, or users about suspected incidents related to a device they represent. They are responsible for forwarding these reports and managing communications with the authorities. * **EUDAMED Registration:** The AR is responsible for verifying the manufacturer's information in the EUDAMED database before it is submitted. * **Termination of Agreement:** If the manufacturer acts contrary to its obligations under the regulation, the AR has the right to terminate the mandate. They must inform the Competent Authority of their Member State and the relevant Notified Body of the termination and the reasons for it. ## A Step-by-Step Framework for AR Due Diligence A systematic evaluation process ensures all critical areas are assessed, allowing for an objective comparison between potential AR providers. #### Step 1: Initial Screening and Longlisting Begin by identifying a pool of potential AR candidates. Sources for finding providers include: * Industry directories and databases. * Recommendations from Notified Bodies (while they cannot endorse a specific one, they may provide a list of known providers). * Referrals from industry consultants or peer companies. * Professional associations and trade groups. At this stage, a quick screening can narrow the list based on basic criteria, such as experience with your device type (e.g., SaMD, implantable devices, Class C IVDs) and general reputation. #### Step 2: Develop a Detailed Request for Proposal (RFP) Create a comprehensive questionnaire to send to your shortlisted candidates. This ensures you receive consistent, comparable information from each provider. The RFP should request detailed responses on the key evaluation criteria outlined in the next section. #### Step 3: Evaluate Proposals and Shortlist Carefully review the RFP responses. Create a scoring matrix to objectively compare candidates across different categories, such as regulatory expertise, scope of services, fee structure, and QMS maturity. Eliminate any providers who provide vague answers, lack relevant experience, or do not have a transparent fee structure. Select the top two or three candidates for the final evaluation stage. #### Step 4: Conduct Interviews and Reference Checks Schedule calls with the final candidates to discuss their proposals in detail. Key goals for this stage include: * **Meet the Team:** Who would be your day-to-day contact? What are their qualifications and experience? * **Probe for Expertise:** Ask scenario-based questions related to your device. For example, "How would you handle a request for technical documentation from the German Competent Authority (BfArM)?" or "Describe your process for managing a reportable incident." * **Request and Contact References:** Ask for references from clients with devices similar to yours. Inquire about their responsiveness, expertise, and overall satisfaction with the service. #### Step 5: Scrutinize the Mandate Agreement and Insurance The final step is a thorough legal and operational review of the AR mandate agreement. This contract governs the entire relationship. Pay close attention to: * **Scope of Work:** A clear definition of all included services. * **Liability Clauses:** How is liability shared and defined? * **Fee Schedule:** A transparent breakdown of all potential costs. * **Termination Clauses:** The conditions under which either party can terminate the agreement. * **Proof of Insurance:** Request a certificate of liability insurance and verify that the coverage is adequate for the risk profile of your products. ## Deep Dive: Key Evaluation Criteria Checklist Use this detailed checklist during your RFP and interview process to ensure a comprehensive assessment. #### 1. Regulatory Expertise and Experience * **Team Qualifications:** What are the backgrounds and credentials of the regulatory staff? Do they have former Notified Body or Competent Authority personnel? * **Device-Specific Experience:** Can they provide evidence of experience with devices of a similar classification, technology, and intended use? * **MDR/IVDR Transition Experience:** How many clients have they successfully supported through the transition to the new regulations? * **Staying Current:** What is their process for monitoring and implementing new MDCG guidance, Common Specifications, and harmonized standards? #### 2. Scope of Services and Fee Structure * **Included Services:** Does the standard fee cover EUDAMED registration support, vigilance reporting, incident management, and communication with authorities? * **Additional Costs:** What services are considered "out of scope" and charged separately (e.g., handling major field safety corrective actions, providing extensive support during an authority inspection)? * **Fee Model:** Is it a flat annual fee, a per-product fee, or a hybrid model? A transparent, predictable model is generally preferable. #### 3. Quality Management System (QMS) and Processes * **ISO 13485 Certification:** Is the AR certified to ISO 13485:2016? This is a strong indicator of a mature and compliant QMS. * **Document Control:** What are their procedures for securely receiving, storing, and providing access to your technical documentation? How do they ensure confidentiality? * **Vigilance & PMS Procedures:** Ask to review their standard operating procedures (SOPs) for handling complaints, incident reporting, and communication with authorities. * **Audit History:** Are they willing to share anonymized results of recent audits by Notified Bodies or other clients? #### 4. Liability, Insurance, and Risk Management * **Liability Insurance:** Request a copy of their liability insurance certificate. Ensure the coverage amount is sufficient for the potential risks associated with your device. * **Contractual Liability:** How does the mandate agreement delineate liability between the manufacturer and the AR? Ensure the terms are clear and fair. ## Finding and Comparing EU Authorized Representative Providers Choosing the right partner is crucial for ensuring market access and long-term compliance in the European Union. Using a specialized directory allows manufacturers to efficiently find, vet, and compare qualified EU Authorized Representative providers. This approach helps streamline the selection process by providing a curated list of providers with verified expertise, enabling you to request proposals from multiple candidates simultaneously and compare their services and fee structures in a structured manner. To find qualified vetted providers [click here](https://cruxi.ai/regulatory-directories/reach_only_rep) and request quotes for free. --- This article is for general educational purposes only and is not legal, medical, or regulatory advice. For device-specific questions, sponsors should consult qualified experts and consider engaging FDA via the Q-Submission program. --- *This answer was AI-assisted and reviewed for accuracy by Lo H. Khamis.*